PRGO
55
5
VFC
15
2
CA
12
-12
D
48
15
RRC
72
3
ADP
61
2
PNW
62
5
DVN
46
2
HAL
54
4
PM
41
-9
MCHP
47
-4
WHR
46
11
SIG
72
2
GRMN
55
-3
MU
35
-12
ROST
51
2
SRE
57
5
AMP
61
4
GOOG
79
14
ALL
48
3
PRGO
55
5
VFC
15
2
CA
12
-12
D
48
15
RRC
72
3
ADP
61
2
PNW
62
5
DVN
46
2
HAL
54
4
PM
41
-9
MCHP
47
-4
WHR
46
11
SIG
72
2
GRMN
55
-3
MU
35
-12
ROST
51
2
SRE
57
5
AMP
61
4
GOOG
79
14
ALL
48
3
Financhill
Back

Ono Pharmaceutical 10K Form

Sell
38

OPHLF
Ono Pharmaceutical

Last Price:
15.96
Seasonality Move:
-4.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OPHLF News And Ratings

See the #1 stock for the next 7 days that we like better than OPHLF

OPHLF Financial Statistics

Sales & Book Value

Annual Sales: $3.31B
Cash Flow: $154.13M
Price / Cash Flow: 11.42
Annual Sales: $11.72
Price / Book: 1.36

Profitability

EPS (TTM): 1.86260
Net Income (TTM): $900.68M
Gross Margin: $2.5B
Return on Equity: 16.49%
Return on Assets: 14.39%

Ono Pharmaceutical Earnings Forecast

Key Ono Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 19 years for OPHLF is 75.39%.
  • The Selling, General & Administrative Expenses for OPHLF have been equal to 20.01% of Gross Profit Margin.
  • The Research & Development expenses have been 21.32% of Revenue.
  • The Interest Expense is 0.81% of Operating Income.
  • The Net Earning history of OPHLF is 25.21% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 10 years.

Ono Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OPHLF
Website: ono.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.95
Quick Ratio: 3.19

Price-to-Earnings

Trailing P/E Ratio: 9.34
Forward P/E Ratio: 0

OPHLF Technical Analysis vs Fundamental Analysis

Sell
38
Ono Pharmaceutical (OPHLF) is a Sell

Is Ono Pharmaceutical a Buy or a Sell?